insights_auto
Why is MEOBF down 13,47%?
Dive Deeperchevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
1,32 $
arrow_downward
-13,47%(-0,21) 1D
14 հոկ, 09:30:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Open
1,32 $
High
1,32 $
Low
1,32 $
Mkt. cap
1,82 մլրդ
Avg. vol.
391,00
Volume
300,00
52-wk high
2,59 $
52-wk low
1,14 $
Beta
1,68
Shares outstanding
1,30 մլրդ
No. of employees
108
Open
1,32 $
High
1,32 $
Low
1,32 $
Mkt. cap
1,82 մլրդ
Avg. vol.
391,00
Volume
300,00
52-wk high
2,59 $
52-wk low
1,14 $
Beta
1,68
Shares outstanding
1,30 մլրդ
No. of employees
108
News stories
From web sources and news partners
Kalkine
·
12 ժամ առաջ
Mesoblast Applies to Quote 2,550,000 Ordinary Shares Issued Under Employee Incentive Scheme on 3 September 2026
TipRanks
·
1 օր առաջ
Mesoblast Posts First Full-Year Ryoncil Revenue Surge and Files 2026 Annual Report
Stock Titan
·
1 օր առաջ
From US$17.2M a year earlier, FY2026 revenue climbs at Mesoblast (MESO).
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd